Researchers' work is providing crucial leads for guiding experimental efforts toward the vaccine development against the novel pneumonia (COVID-19) caused by the virus
Stressmarq Biosciences will work with Cellectricon to enable the collaborative development of next-generation reagents and assays for neurodegenerative disease research